Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa
Artículo

Open/ Download
Publication date
2015Metadata
Show full item record
Cómo citar
O'Ryan Gallardo, Miguel
Cómo citar
Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa
Abstract
A decade after licensure of the human rotavirus vaccine (HRV), a wealth of evidence supports a reduction of rotavirus (RV) gastroenteritis-associated mortality and hospitalizations following HRV inclusion in national immunization programs. Nevertheless, the majority of real-world data has been generated in high-or middle-income settings. Clinical efficacy trials previously indicated RV vaccine performance may be lower in less-developed countries compared with wealthier counterparts. Using recently published data from Africa, we examine the effectiveness and impact of HRV in resource-deprived areas, exploring whether vaccine performance differs by socioeconomic setting and the potential underlying factors. HRV vaccine effectiveness in early adopting African countries has proven to be similar or even superior to the efficacy results observed in pre-licensure studies.
General note
Artículo de publicación ISI
Identifier
URI: https://repositorio.uchile.cl/handle/2250/134992
DOI: DOI: 10.1586/14760584.2015.1059282
Quote Item
Expert Rev. Vaccines 14(8), 1099–1112 (2015)
Collections
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Chile
Related items
Showing items related by title, author, creator and subject.
-
Suárez, Eugenio; Smit, Jennifer S.; Bosch, F. Xavier; Nieminen, Pekka; Chen, Chien-Jen; Torvinen, Saku; Demarteau, Nadia; Standaert, Baudouin (ELSEVIER SCI LTD, 2008-09-15)Mathematical models provide valuable insights into the public health and economic impact of cervical cancer vaccination programmes. An in-depth economic analysis should explore the effects of different vaccine-related ...
-
O'Ryan Gallardo, Miguel; Vidal, Roberto; Del Canto, Felipe; Salazar, Juan Carlos; Montero, David (Taylor and Francis Inc., 2015)© 2015 Taylor & Francis Group, LLC.Efforts to develop vaccines for prevention of acute diarrhea have been going on for more than 40 y with partial success. The myriad of pathogens, more than 20, that have been identified ...
-
Rey Jurado, Emma; Tapia, Felipe; Muñoz Durango, Natalia; Lay, Margarita K.; Carreño Marquez, Leandro J.; Riedel, Claudia A.; Bueno, Susan M.; Genzel, Yvonne; Kalergis, Alexis M. (Frontiers Media SA, 2018)Vaccines have significantly reduced the detrimental effects of numerous human infectious diseases worldwide, helped to reduce drastically child mortality rates and even achieved eradication of major pathogens, such as ...